Join

Compare · RVP vs WST

RVP vs WST

Side-by-side comparison of Retractable Technologies Inc. (RVP) and West Pharmaceutical Services Inc. (WST): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both RVP and WST operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • WST is the larger of the two at $22.07B, about 1135.8x RVP ($19.4M).
  • Over the past year, RVP is down 10.7% and WST is up 41.7% - WST leads by 52.4 points.
  • WST has been more active in the news (4 items in the past 4 weeks vs 2 for RVP).
  • WST has more recent analyst coverage (15 ratings vs 0 for RVP).
PerformanceRVP-10.72%WST+41.67%
2025-04-28+0.00%2026-04-24
MetricRVPWST
Company
Retractable Technologies Inc.
West Pharmaceutical Services Inc.
Price
$0.65-0.62%
$306.12-1.10%
Market cap
$19.4M
$22.07B
1M return
-8.30%
+23.98%
1Y return
-10.72%
+41.67%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
AMEX
NYSE
IPO
2001
News (4w)
2
4
Recent ratings
0
15
RVP

Retractable Technologies Inc.

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holder; allergy tray; IV safety catheter; Patient Safe syringes and Luer Caps; VanishPoint blood collection set; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

WST

West Pharmaceutical Services Inc.

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Latest RVP

Latest WST